missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant SARS-CoV-2 Spike RBD Fc Chimera Protein
CHO Expressed, High ACE-2 Binding
Marke: R&D Systems™ 10542-CV-100
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
Measured by its binding ability in a functional ELISA with Recombinant Human ACE-2 His-tag Measured by its binding ability in a functional ELISA with Recombinant Human ACE-2 His-tag (Catalog # 933-ZN ).Spezifikation
| YP_009724390.1 | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. | |
| M.W.-observed: 55-66 kDa, under reducing conditions, M.W.-theoretical: 52 kDa | |
| Chinese Hamster Ovary cell line, CHO-derived sars-cov-2 Spike RBD protein SARS-CoV2 Spike RBD (Arg319-Phe541) (N-terminus) Accession # YP_009724390.1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) | |
| <0.10 EU / 1 μg of the protein by the LAL method. | |
| Unconjugated | |
| >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Bioactivity | |
| 43740568 | |
| 100 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
| 2019-nCoV Peplomer protein, 2019-nCoV S Protein, 2019-nCoV Spike, COVID-19 Spike, E2, Human coronavirus spike glycoprotein, Peplomer protein, S glycoprotein, S protein, SARS-CoV-2, SARS-COV-2 E2, SARS-COV-2 Peplomer protein, SARS-COV-2 S protein, SARS-COV-2 Spike glycoprotein, SARSCOV2 Spike protein, Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein, Spike, Spike glycoprotein, Spike S1, Spike S1 RBD, surface glycoprotein | |
| Reconstitute at 500 μg/mL in PBS. | |
| SARS-CoV-2 Spike RBD |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur